Alternatives to Alithea Genomics
Alithea Genomics is a Biotechnology tool: unlocking industrial-scale RNA-seq for primary drug screening and toxicology. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Alithea Genomics
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
BiotechnologymRNA TechnologyUpdated 9 Jul 2026
Mammoth BiosciencesNot ratedBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
BiotechnologyDrug DiscoveryUpdated 26 Sept 2026
Pixelgen TechnologiesNot ratedA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
BiotechnologyLife SciencesUpdated 24 Aug 2026
VizgenNot ratedSpatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.
BiotechnologyLife SciencesUpdated 13 Sept 2026
QuartzyNot ratedA vertically-integrated procurement platform for the life sciences industry.
BiotechnologyLife SciencesUpdated 14 Apr 2026
Adaptyv BiosystemsNot ratedAutomated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.
BiotechnologyArtificial IntelligenceUpdated 29 Aug 2026- TOTolemy BioNot rated
AI-enabled technology for cell biology research and biopharma development.
BiotechnologyArtificial IntelligenceUpdated 1 Jul 2026
Epicrispr BiotechnologiesNot ratedEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
BiotechnologyTherapeuticsUpdated 18 Aug 2026
AbcamNot ratedGlobal supplier of life science research tools, including antibodies, reagents, and assays.
BiotechnologyLife SciencesUpdated 24 May 2026
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
BiotechnologyPharmaceuticalsUpdated 19 Aug 2026
Network BioNot ratedLeveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.
BiotechnologyArtificial IntelligenceUpdated 25 Sept 2026
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
BiotechnologyDrug DiscoveryUpdated 8 Aug 2026
FreenomeNot ratedFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
BiotechnologyHealthcareUpdated 22 Sept 2026
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
BiotechnologyPharmaceuticalsUpdated 1 May 2026
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
BiotechnologyPharmaceuticalsUpdated 8 Aug 2026
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
BiotechnologyGene TherapyUpdated 12 Aug 2026
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
BiotechnologyHealthUpdated 25 Aug 2026- EAEarendil LabsNot rated
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
BiotechnologyArtificial IntelligenceUpdated 23 Aug 2026
CausalyNot ratedAI-powered knowledge discovery for life sciences.
BiotechnologyArtificial IntelligenceUpdated 12 Apr 2026
CellaresNot ratedThe first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.
BiotechnologyPharmaceuticalsUpdated 1 Sept 2026
Showing the 20 closest matches. See the rest on the Alithea Genomics profile.